SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: v162735_ex99-1.htm 2 EX-99.1
[v162735_ex99-1.htm 2 EX-99.1]
BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)
[BIOSTAR PHARMACEUTICALS, INC. RECEIVES PATENT FOR AOXING GANBAO Press Release Source: Biostar Pharmaceuticals, Inc. On Friday October 2, 2009, 8:00 am EDT BSPM News ; XIANYANG, China, Oct. 2 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: Aoxing Ganbao is a traditional Chinese herbal product that is complementary for its flagship Xin Aoxing Oleanolic Acid Capsule to treat Hepatitis B.]
BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, INC. RECEIVES PATENT FOR AOXING GANBAO
[BIOSTAR PHARMACEUTICALS, INC. RECEIVES PATENT FOR AOXING GANBAO Press Release Source: Biostar Pharmaceuticals, Inc. On Friday October 2, 2009, 8:00 am EDT BSPM News ; XIANYANG, China, Oct. 2 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: Aoxing Ganbao is a traditional Chinese herbal product that is complementary for its flagship Xin Aoxing Oleanolic Acid Capsule to treat Hepatitis B.]
CPHI [CHINA PHARMAS,] 424B3: (Original Filing)
[FORM 8-K CURRENT REPORT October 1, 2009 China Pharma Holdings, Inc ------------------------------ Delaware (State or other jurisdiction of incorporation) 000-29532 73-1564807]
CPHI [CHINA PHARMAS,] 424B3: FORM 8-K CURRENT REPORT October 1, 2009 China
[FORM 8-K CURRENT REPORT October 1, 2009 China Pharma Holdings, Inc ------------------------------ Delaware (State or other jurisdiction of incorporation) 000-29532 73-1564807]
CPHI [CHINA PHARMAS,] 8-K: (Original Filing)
[China Pharma Holdings, Inc. Announces Approval for NYSE Amex Listing HAIKOU CITY, China, September 28, 2009 - China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it has received approval to list its securities on NYSE Amex. China Pharma expects to begin trading on NYSE Amex]
CPHI [CHINA PHARMAS,] 8-K: China Pharma Holdings, Inc. Announces Approval for NYSE
[China Pharma Holdings, Inc. Announces Approval for NYSE Amex Listing HAIKOU CITY, China, September 28, 2009 - China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it has received approval to list its securities on NYSE Amex. China Pharma expects to begin trading on NYSE Amex]
CPHI [CHINA PHARMAS,] 424B3: (Original Filing)
[FORM 8-K CURRENT REPORT October 1, 2009 China Pharmas, ------------------------------ Delaware (State or other jurisdiction oforporation) 000-29532 73-1564807 (IRS Employer Identification Number) 2nd Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 86-898-66811730fe Harbor Statement under the Private Securities Litigation Reform Act of 1995 Item 8.01. Other Events.]
CPHI [CHINA PHARMAS,] 424B3: FORM 8-K CURRENT REPORT October 1, 2009 China
[FORM 8-K CURRENT REPORT October 1, 2009 China Pharmas, ------------------------------ Delaware (State or other jurisdiction oforporation) 000-29532 73-1564807 (IRS Employer Identification Number) 2nd Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 86-898-66811730fe Harbor Statement under the Private Securities Litigation Reform Act of 1995 Item 8.01. Other Events.]
CPHI [CHINA PHARMAS,] 8-K: (Original Filing)
[China Pharmas, Announces Approval for NYSE Amex Listing HAIKOU CITY, China, September 28, 2009 - China Pharmas, ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and marketsecialty pharmaceutical products in China, today announced that it has received approval to list its securities on NYSE Amex.]
